Tobechukwu J Okobi

60PUBLICATIONS

399CO-AUTHORS

Molecular targetsRadiation therapyCancer diagnosisCancer geneticsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (60)

Sort by Publication Date:

|Jun 26, 2026

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

|May 30, 2026

Top advances of the year: Radiopharmaceutical therapy for prostate cancer.

|May 11, 2026

Temporal Trends in the Frequency of Concomitant Cancer and Cerebrovascular Disease Diagnoses in the United States.

|Feb 26, 2026

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Feb 09, 2026

Assessing the patient reported outcomes (PROs) of enfortumab vedotin plus pembrolizumab versus platinum-based chemotherapy in patients with advanced urothelial carcinoma in the EV-302 study.

Tobechukwu J Okobi, Neil Vaishampayan, Deepthi Subramanya

|Jan 26, 2026

Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.

Bradley J Stish, Gina L Mazza, Jones T Nauseef

Pageof 10

Frequent Collaborators

10 joint publications

Cora N Sternberg

10 joint publications

Michael Sigouros

10 joint publications

Himisha Beltran

Olivier Elemento

Andrew J Armstrong

Juan Miguel Mosquera

Andrea Sboner

Michael J Morris

Bishoy Morris Faltas

Joshua M Lang

Frequent Collaborators

10 joint publications

Cora N Sternberg

10 joint publications

Michael Sigouros

10 joint publications

Himisha Beltran

7 joint publications

Olivier Elemento